Insider Cluster (2 insiders) ·Filed Aug 24, 2026

DXCM

DEXCOM INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $1.9M total
Actionable Insight • Neutral

Insider sales are trivial relative to market cap and likely reflect routine portfolio diversification or tax planning. No bearish signal. Monitor next 8-K or earnings release for any fundamental changes, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
DXCM ▼ -1.68% at T+20d
NEUTRAL call ✗ call lost -1.68% · α vs SPY -2.99% · entry $91.06 → $89.53
Next anchor: T+60d in 6w
Latest observation: T+26 -15.43% FF3 residual α
Entry anchored
Aug 21, 07:55 PM ET
via 1-min bar
T+1d
-2.09%
call -2.09% · α -2.41%
$89.16
settled 6w ago
T+5d
0.00%
call 0.00% · α -0.47%
$91.06
settled 5w ago
T+20d
-1.68%
call -1.68% · α -2.99%
$89.53
settled 11d ago
T+60d
—
call — · α —
—
in 6w

Price Chart

Loading chart...

Executive Summary

Executive Chair Kevin Sayer sold ~$2.4M worth of DXCM shares in two open-market transactions on August 20, 2026, and EVP/Chief Legal Officer Michael Brown sold ~$156K on August 14. The combined $1.89M cluster represents ~0.005% of DXCM's $34.8B market cap — a trivial amount. No C-suite buying occurred. The sales are routine in size and likely liquidity-driven, not indicative of negative inside information.

Key Financial Metrics

Direction
selling
Total Value
$1.9M
Insiders
2

Key Facts

  • Executive Chair Kevin Sayer sold 26,756 shares total (~$2.41M) on August 20, 2026
  • EVP/Chief Legal Officer Michael Brown sold 1,700 shares (~$156K) on August 14, 2026
  • Total cluster value of $1.89M represents ~0.005% of DXCM's $34.8B market cap
  • No insider purchases in the cluster; net direction is selling
  • All transactions are open-market sales (code S)

Financial Impact

$1.89M in insider sales, ~0.005% of market cap — immaterial

insider ownership

Risk Factors

  • No insider buying to offset the sales — but sales are too small to be informative
  • Executive Chair selling ~$2.4M could be misinterpreted by retail as bearish
  • No recent 10b5-1 plan disclosure to confirm these are pre-planned

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (36 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DXCM-1787642074788
11 reports for DXCM
Performance horizon
Filters
Rows
Reports for DXCM — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
8-K
NEUTRAL ★ 2/10
$86.45 $89.53▲ +3.56%▲ +1.44%$86.23 (−0.25%)
Aug 28, 2026
4w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $84.53▼ −7.17%▼ −7.03%$86.23 (−5.30%)
Aug 24, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.06 $91.06· 0.00%▼ −0.47%$86.23 (−5.30%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$88.76 $91.06▲ +2.59%▲ +3.78%$86.23 (−2.85%)
Jul 21, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.43 $75.14▲ +5.19%▲ +7.60%$86.23 (+20.72%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$72.47 $68.65▼ −5.27%▼ −3.61%$86.23 (+18.99%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$70.17 $73.45▲ +4.67%▲ +3.46%$86.23 (+22.88%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 2/10
$70.17 $72.70▲ +3.61%▲ +3.14%$86.23 (+22.88%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$71.24 $72.27▲ +1.45%▼ −0.36%$86.23 (+21.04%)
Apr 15, 2026
24w ago
DEFA14A
NEUTRAL ★ 2/10
$61.01 $62.68▲ +2.74%▲ +1.75%$86.23 (+41.33%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 5m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 25, 2026